Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
about
MiR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locusOverexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic CancerPost-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]miRNA expression in colon polyps provides evidence for a multihit model of colon cancerDistinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemiaAltered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritisAn integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcomamiR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cellsMiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human gliomaAn integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cellsPrediction and preliminary validation of oncogene regulation by miRNAsA conserved gene structure and expression regulation of miR-433 and miR-127 in mammalsA decade of exploring the cancer epigenome - biological and translational implicationsMicroRNAs: control and loss of control in human physiology and diseaseMutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia?Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaMicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass indexmiRNAs in human cancerMiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progressionEpigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancerRDX induces aberrant expression of microRNAs in mouse brain and livermicroRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cellsMicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery componentsTherapeutic microRNA strategies in human cancerTranscriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgammamiRecords: an integrated resource for microRNA-target interactionsMethylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisMicroRNA-127 modulates fetal lung developmentChromosomal rearrangements and microRNAs: a new cancer link with clinical implicationsA potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancerPotential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerMicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological DiseasesMicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerWhat Do We Know about the Role of miRNAs in Pediatric Sarcoma?MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerMicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to TherapyThe Role of Epigenetics in Arterial CalcificationMicroRNAs: molecular features and role in cancerHow microRNAs influence both hereditary and inflammatory-mediated colon cancers
P2860
Q21092170-B4AAEDCA-A8AD-4B6C-AA1B-F0209ABF88B9Q21129296-AFA8A87A-40C0-4907-9F09-34543E1C3266Q21133528-74BD1305-EB2B-49DD-8190-E81421034E4AQ21135357-5428B148-4A81-4C81-834E-EED0EF878BEAQ21144312-B7F369F7-7683-4EB2-9A6E-689BD92D3A3EQ21195360-5CC97DB3-833F-4F48-8DD2-2FB4128E1C60Q21198840-294CFE40-A027-4A3E-ABDA-55E26ECAEDA5Q21245271-83431C50-0775-4B83-8D59-C53C5D852BCAQ21245768-2FDE5DFC-E225-4751-8A2A-6FB6C56D74B0Q21245772-CF7F21D7-A97C-4EED-A742-EEE15B80966DQ21262991-70BEDB45-AC99-4216-A359-DC9D13E7744BQ21562344-C7F7CE69-7ADA-4425-942E-3DC8165AE00CQ24614467-4B3D85B2-20B8-4869-B07F-2A37E199D915Q24618771-24D4E139-B4EB-41C2-B070-E8C9110E0A05Q24620478-256A1595-50F7-4C03-954A-5943BD99A956Q24627680-4E7C8B63-7C77-4DB6-BC11-28962164AE38Q24628888-2D55EE03-1238-4CA4-8F13-292B29AA8614Q24628889-C1B2BBBD-EEF5-4D9B-B207-D5956DA7DC50Q24643470-A5EA2AC9-569A-47A1-9319-CA5F93030F19Q24645509-E5750977-B088-4DF4-AFE7-BFC58F756D80Q24647072-E29E1C8A-64F0-4643-A358-AC0A6CB1716CQ24648506-A555B62F-0610-4D9E-88BD-40320DFC15B8Q24648543-01D0E690-5501-419D-9694-F0BEFAA608DAQ24651333-546CEE49-2691-4AF8-9BD8-004ABC8DFA73Q24653021-6A12F526-8640-456F-896E-420C29F18786Q24655642-513DAFAD-0D34-4CB8-A00C-A98C23FE4177Q24656948-29550BEC-F522-49A5-8B9A-50E827D2CF17Q24657624-92E676AD-FAE6-4AB5-9F3F-FBF1CADB4C72Q24683729-D708D9E3-26C8-420F-9782-E9A9A6BE70AFQ26740327-7D415931-97E5-492F-A20B-43748F2D7065Q26744362-AE638C08-8966-4470-A953-59D53B23B680Q26744819-5DCB3DB1-ED81-48CD-9287-A29DF51DB42EQ26750448-0DD0EE6B-4DBB-40E4-802D-17E8A3CBE3A7Q26775086-325B9509-A1B0-42EE-A316-CB41D5CF451DQ26800124-0D4AE656-3A7F-4F06-84FD-61486167D602Q26801108-56327DD4-436F-4044-8F4A-0EE36FCDD18CQ26801487-431DE0FB-7A58-4B80-9E20-C9C73B4BDF49Q26801901-F627E337-D5A2-4374-8630-D373AD0A0DDCQ26822633-43AC8BD6-4A80-47CC-9A7B-005435223FDBQ26823451-0627D06D-294A-4539-A969-FFFCD0E72478
P2860
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Specific activation of microRN ...... ng drugs in human cancer cells
@ast
Specific activation of microRN ...... ng drugs in human cancer cells
@en
Specific activation of microRN ...... ng drugs in human cancer cells
@nl
type
label
Specific activation of microRN ...... ng drugs in human cancer cells
@ast
Specific activation of microRN ...... ng drugs in human cancer cells
@en
Specific activation of microRN ...... ng drugs in human cancer cells
@nl
prefLabel
Specific activation of microRN ...... ng drugs in human cancer cells
@ast
Specific activation of microRN ...... ng drugs in human cancer cells
@en
Specific activation of microRN ...... ng drugs in human cancer cells
@nl
P2093
P3181
P1433
P1476
Specific activation of microRN ...... ng drugs in human cancer cells
@en
P2093
Gerhard A Coetzee
Jeffrey M Friedman
Jody C Chuang
Peter A Jones
Yoshimasa Saito
P304
P3181
P356
10.1016/J.CCR.2006.04.020
P407
P577
2006-06-01T00:00:00Z